Aripiprazole in psychosis associated with Parkinson's disease

J Neuropsychiatry Clin Neurosci. 2005 Summer;17(3):421-2. doi: 10.1176/jnp.17.3.421.

Abstract

Aripiprazole is an agent for treating schizophrenia. The authors assume that aripiprazole as a dopamine receptor partial agonist may be useful in treating PD patients. Three cases are presented in this study. All patients were evaluated by the same clinician, a neuropsychiatrist well trained in the use of Brief Psychiatric Rating Scale (BPRS) and Clinical Global Impression (CGI). Aripiprazole was effective for reducing psychosis in each case.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antipsychotic Agents / therapeutic use*
  • Aripiprazole
  • Female
  • Humans
  • Male
  • Mental Disorders / complications
  • Mental Disorders / drug therapy*
  • Middle Aged
  • Parkinson Disease / complications*
  • Piperazines / therapeutic use*
  • Psychiatric Status Rating Scales
  • Quinolones / therapeutic use*

Substances

  • Antipsychotic Agents
  • Piperazines
  • Quinolones
  • Aripiprazole